Spots Global Cancer Trial Database for Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)

Official Title: Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)

Study ID: NCT00682890

Conditions

Polycystic Ovary Syndrome

PCOS

Insulin Sensitivity

Interventions

placebo

metformin

Study Description

Brief Summary: The purpose of this research study is to determine if adding Metformin, a drug that reduces insulin resistance, to birth control pills will reduce the risk of developing type 2 diabetes, high blood pressure. high lipid levels and heart disease in women with PCOS

Detailed Description: Inclusion criteria: PCOS women between the ages of 18-45,\< 8 periods annually, elevated serum free testosterone, normal thyroid function tests and serum prolactin, exclusion of late onset adrenal hyperplasia, acceptable health based on interview and medical history, physical exam and lab tests, ability to comply with the requirements of the study and to provide signed, witnessed informed consent.